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The apoptosis-associated speck-like protein containing a caspase recruit domain (ASC) is involved in apoptosis and innate
immunity and is a major adaptor molecule responsible for procaspase-1 activation. ASC mRNA is encoded by three exons: exons 1
and 3 encode a pyrin domain (PYD) and caspase recruit domain (CARD), respectively, and exon 2 encodes a proline and glycine-
rich (PGR) domain. Here, we identiﬁed a variant ASC protein (vASC) lacking the PGR domain that was smaller than full length
ASC (fASC) derived from fully transcribed mRNA and searched for diﬀerences in biochemical and biological nature. Both fASC
and vASC were found to activate procaspase-1 to a similar degree, but the eﬃciency of IL-1β excretion was signiﬁcantly higher for
vASC. There was also a marked structural diﬀerence observed in the ﬁbrous aggregates formed by fASC and vASC. These results
suggest that although the PGR domain is dispensable for procaspase-1 activation, it plays an important role in the regulation of
the molecular structure and activity of ASC.
Copyright © 2009 Kazuhiko Matsushita et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
1.Introduction
Cytosolic pathogen receptors and their downstream
molecules have recently garnered attention in the ﬁeld of
inﬂammation and innate immunity. One such molecule,
the apoptosis-associated speck-like protein containing a
caspase recruit domain (ASC), is an adapter molecule
consisting of a caspase recruit domain (CARD) and pyrin
domain (PYD) that was ﬁrst identiﬁed in our laboratory
as a proapoptotic protein [1, 2]. The entire cDNA of ASC
cloned by immunoscreening and RACE (rapid ampliﬁcation
of cDNA ends) has revealed that the open reading frame
of 585bp contains a PYD (1–90 amino acids) and a CARD
(107–195 amino acids) [1]. According to GenBank accession
number NP 037390, the cDNA of ASC consists of exon 1:
1–90 amino acids, exon 2: 91–110 amino acids, and exon
3: 111–195 amino acids. As for isoforms, an alternatively-
spliced form of ASC lacking the PGR domain encoded
by exon 2 of ASC was detected in IMR90 human diploid
ﬁbroblasts and 90SV ﬁbroblasts by Conway et al. [3], and a
short form of ASC (192kDa) was found in THP-1 cells by
Fernandes-Alnemri [4]. An ASC protein lacking 19 amino
acids, which are encoded by exon 2 of ASC, is also reported
in GenBank as isoform b (NP 660183).
ASC functions as a mediator in the cytosol-type inﬂam-
matory signaling pathway as well as a downstream molecule
in Toll-like receptor signaling. ASC has been established
to activate procaspase-1 [5] through its oligomerization in
inﬂammasomes and process proIL-1β and proIL-18 into IL-
1β andIL-18,respectively[6–8],leadingtotheestablishment
of innate immunity. Inﬂammasomes are formed by nucle-
oside oligomerization domain (NOD) like-receptor (NLR)
family members, the adapter protein ASC, procaspase-1, and
caspase-5 in some form of inﬂammasome [9]. Mutations
in the basic components of inﬂammasomes appear to be
responsibleforseveralautoinﬂammatorydiseases;mutations2 Mediators of Inﬂammation
in the CIAS1 (cold induced autoinﬂammatory syndrome 1)
gene encoding cryopyrin or in the MEFV (Mediterranean
fever) gene encoding pyrin perturb the function of ASC
and the consequent activation of procaspase-1 and IL-1β
processing [10].
ASC also plays an important role in an inﬂamma-
tory form of cell death called pyroptosis [4, 11]. During
pyroptosis, some ligands activate pyrin by unmasking its
PYD in the pyroptosome, thereby allowing it to interact
with ASC and facilitating ASC dimerization into an active
ASC pyroptosome that activates caspase-1 [12]. However,
the PYD of pyrin is reported to interfere with the ability
of cryopyrin to associate with ASC, indicating negative
regulation of ASC proximity in inﬂammasomes [13]. Since
the oligomerization of ASC clearly plays a pivotal role in
innate immunity and pyroptosis to activate caspase-1 but
the function of the PGR domain remains to be clariﬁed,
we investigated the regulation of molecular structure and
activity of a variant form of ASC (vASC) with a missing PGR
domain in comparison with that of full length ASC (fASC).
2.MaterialsandMethods
2.1. Detection of an ASC Variant (vASC) In HL-60 Cells
by Mass Spectrometry. HL-60 cells were cultured in RPMI
1640 supplemented with 10% fetal bovine serum. ASC and
an unidentiﬁed Protein X separated by SDS–PAGE using
antihumanASCmonoclonalantibody(MBL,Nagoya,Japan)
were excised from a gel after staining with Coomassie
brilliant blue R-250 and digested using a Montage In-Gel
Digest96 Kit (Millipore.com, Massachusetts, USA) according
to the manufacturer’s protocol. The puriﬁed peptides were
then analyzed with α-CHCA (cyano-4-hydroxycinnamic
acid) by MALDI-TOF MS. A Voyager Elite XL Biospectrom-
etry workstation (PerSeptive Biosystem, Framingham, MA)
equipped with a delayed extraction ion source was used for
MALDI-TOF MS analysis in the reﬂector mode with the
following parameters: accelerating voltage, 22kV; grid volt-
age, 80% of accelerating voltage; guide wire voltage, 0.05%
of accelerating voltage; and delay time, 200nanoseconds. A
nitrogen laser (337nm) was used for ionization. Calibration
wasperformedusingthemonoisotopicpeaksoftheα-CHCA
dimer (379.0930m/z), angiotensin I (1296.6853m/z), and
ACTH (7–38 clip) (3657.9294m/z).
2.2. Preparation of Expression Vectors. The cDNAs of human
fASC, vASC, procaspase-1, and pro1L-1β were prepared from
H L - 6 0m R N Ab yR T - P C R( R N AL AP C RK i t ,T a k a r aB i o ,
Otsu, Japan) and cloned into pcDNA3 vectors (Invitrogen,
Carlsbad, CA, USA).
2.3. Western Blotting and Immunostaining. The prepared
procaspase-1andproIL-1β andevenfASC orvASC expression
vectors were cotransfected into Cos7 cells using FuGENE6
Transfection Reagent (Roche, Mannheim, Germany) for
transient gene-expression. The cells were dissolved with
1% SDS 24hours after transfection, and then samples
were loaded onto an SDS-PAGE 6–15% polyacrylamide gel,
transferred to PVDF membranes, and developed by ECL
(GE Healthcare, Buckingham, UK). Antibodies of Caspase-
1a n dI L - 1 β were obtained from Santa Cruz (California,
USA). For cellular immunostaining, cells were ﬁxed in a 37%
formaldehyde solution, stained with Cy3-ASC antibody and
Hoechst 3342, and observed with an immunoﬂuorescense
microscope (Axiovert S100, Carl Zeiss, Tokyo, Japan).
2.4. Measurement of Excreted IL-1β. IL-1β excreted by
Cos7 cells cotransfected with expression—vectors (30ng
procaspase-1 and 100ng proIL-1β with 50ng fASC or vASC)
was measured 24hours after plating using a Human IL-
1β immunoassay kit (R and D systems, Minneapolis, USA)
according to manufacturer’s instructions.
2.5. Statistical Analysis. Analysis of variance was performed
andthediﬀerencesbetweengroupsineachsetwereevaluated
byFisher’sprotectedleastsigniﬁcantdiﬀerencetestusingStat
View5.0software(SUSInstitute,Inc.,Berkley,CA,USA).All
values were expressed as mean ± standard error (SE) of the
mean. A P value of less than .05 was considered signiﬁcant.
3. Results
3.1. Analysis of Protein X by Mass Spectrometry. When HL-
60 cells were subjected to SDS-PAGE, anti-ASC antibody
detected one band of 23kDa, which corresponds to fASC,
and another of 20kDa, called Protein X (Figure 1(a),
right lane). A mouse IgG control is shown in Figure 1(a),
left lane. Aﬃnity-puriﬁed polypeptides from HL-60 cell
lysates incubated with anti-ASC antibody are displayed in
Figure 1(b). The unknown protein X was then treated by
trypsin ingel digestion and analyzed with MALDI-TOF MS
(Figure 1(c)), and peptide mass data were subjected to a
database search using MS-Fit, a peptide mass ﬁngerprinting
program from the University of California, San Francisco.
Since the N and C terminal sequences of protein X were
conﬁrmed to be the same as fASC but lacked the amino
acid sequence corresponding to the PGR domain (Figures
1(d) and 1(e)), we were able to identify protein X as
vASC lacking a PGR domain. The sequence of vASC cDNA
from mRNA extracted from HL-60 cells is displayed in
Figure 1(f) and conﬁrms deletion of exon 2 from fASC. This
vASC corresponds to a protein reported in the GeneBank
as association number NP 660183. Thus, protein X was
not a degraded ASC but rather a variant form of ASC
derived from alternatively spliced mRNA missing exon 2 of
the ASC gene.
Next, fASC or vASC cDNA expression vectors were
transfected into Cos7 cells and, 23kDa and 20kDa pro-
teins were induced, respectively (Figure 2). Both of these
exogenously expressed proteins were the same size as the
endogenous ASC-related products found in HL-60 cells
seen in PAGE (Figure 1(a)). Since the Cos7 cells used in
transfection experiments were derived from African Green
Monkey kidney ﬁbroblasts, endogenous expression of fASC
or vASC was not detected in Cos7 cells by antihuman ASC
antibody.Mediators of Inﬂammation 3
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Figure 1: Analysis of protein X by mass spectrometry. (a) HL-60 cells were subjected to SDS-PAGE and western blot analysis using
antihuman ASC antibody. In addition to full length ASC (fASC), an additional polypeptide of 20kDa (Protein X) was detected. (b) Proteins
that were aﬃnity-puriﬁed using anti-ASC antibody were stained with Coomassie Blue. HC: Ig heavy chain, LC: Ig light chain. (c) Mass
spectrum of digested protein X is shown. (d) Structures of ASC and Protein X. Homologous regions are underlined. aa: amino acid. (e)
Amino acid sequence of fASC from a database (GenBank Accession no. NP 037390) and Protein X is displayed. Homologous sequences are
underlined. The amino acid sequence written in light characters was not detected in Protein X. (f) Sequence of ASC cDNA extracted from
HL-60 cells as Protein X is shown.
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Figure 2: Molecular size comparison of endogenous (HL-60)
and exogenous (Cos7) fASC and vASC proteins. Western blotting
of endogenous fASC and vASC in HL-60 cells and exogenously
expressed products of pcDNA3 fASC and pcDNA3 vASC in Cos7
cells. The band of fASC is 23kDa and that of vASC is 20kDa.
3.2. ASC-Dependent Activation of Procaspase-1 and IL-1β.
When the expression vectors of procaspase-1 and, proIL-1β
with fASC or procaspase-1 and proIL-1β with vASC were
expressed in Cos7 cells, the 45kDa band of procaspase-1
decreased in both cases while the activated 20kDa form
appeared (Figure 3). The expression level of caspase-1 versus
fASC in fASC-transfected cells measured using NIH imaging
from triplicate experiments was not signiﬁcantly diﬀerent
from that of vASC, indicating that caspase-1 was activated
by both fASC and vASC at comparable levels (Figure 3).
Similar ﬁndings were observed between the two proteins
for the 31kDa band of pro IL-1β and the 17kDa-activated
form of IL-1β. Additionally, the expression level of IL-1β
versus fASC in fASC-transfected cells measured using NIH
imaging from triplicate experiments was not signiﬁcantly
diﬀerent from that of vASC (Figure 3). However, since the
l e v e lo fa c t i v eI L - 1 β as detected by western blotting was
relatively low, we suspected that a large amount of active4 Mediators of Inﬂammation
Procaspase-1
ProIL-1β
fASC
vASC
Procaspase-1
ProIL-1β
Caspase-1
IL-1β
fASC or vASC
_
_ _ _
_ _
+
+
+
+
+
+
+
++
+
Figure 3: Comparison of caspase-1 and IL-β activation between
fASC and vASC. Western blotting of coexpressed procaspase-1 and
proIL-1β with fASC or vASC in Cos7 cells. Procaspase-1: 45kDa,
caspase-1 (active form): 20kDa, proIL-1β:3 1k D a , I L - 1 β(active
form): 17kDa.
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Figure 4: Comparison of excreted IL-1β levels. IL-1β in the
culture medium of Cos7 cells cotransfected with expression vectors
(procaspase-1 and proIL-1β with fASC or vASC) was measured
by ELISA. Results are shown as mean ± SE.n = 3,
∗P <. 05.
Expression levels of fASC and vASC are shown under the graph.
IL-1β could have been excreted from the cells. Surprisingly,
when we examined IL-1β levels in the medium, the amount
of IL-1β was signiﬁcantly higher in the vASC transfectants
than in the fASC transfectants (n = 3,P<. 05, Figure 4).
Representative western blotting data of fASC and vASC from
three experiments are displayed in Figure 4, under the graph.
Although protein levels of vASC were smaller than those of
fASC, the amount of released IL-1β was higher.
3.3. Intracellular Distribution of fASC and vASC. The distri-
bution of exogenously transfected gene products was exam-
ined in Cos7 cells. Both products were seen to form ﬁbrous
aggregates (Figure 5) ,b u tf A S Cf o r m e dt y p i c a lc i r c u l a r
fASC
(a) (b) (c)
vASC
(d) (e) (f)
Figure 5: Intracellular distribution of fASC and vASC in Cos7 cells.
Expression vectors of fASC or vASC were transfected into Cos7
cells. (a), (d): aggregation of fASC and vASC, scale bar: 30μM.
(b), (e): magniﬁed pictures of (a) and (d), scale bar: 5μM. (c), (f):
aggregations with nuclei, scale bar: 5μM.
ﬁbrous aggregates whereas those of vASC were branched;
almost 40% of fASC-expressing cells exhibited a diﬀused
fASC pattern and 60% of cells formed circular ﬁbrous
aggregates, but vASC formed branched ﬁbrous aggregates in
all cells expressing it.
4. Discussion
The homophilic interactions of the N-terminal PYD and C-
terminal CARD domains have been revealed by immunopre-
cipitation to be involved in the self-association and ﬁlament-
like aggregation of ASC [14]. PYD has been shown to
mediate the self-association of ASC [15]. ASC and PYD-
family proteins seem to interact via their PYD domain [16],
while the CARD domain of ASC has been shown to bind
to the CARD domain of caspase-1 [1, 17, 18]. Ectopic
expression of full-length ASC, but not its isolated CARD
or PYD domains, with procaspase-1 previously induced
activation of procaspase-1 and processing of proIL-1β in
transfectedcells.Thus,PYDfunctionsastheoligomerization
domain, and CARD functions as the eﬀector domain of ASC
in the caspase-1 activation pathway [18]. In spite of these
discoveries, the role of the PGR domain, which is located
between PYD and CARD, remains unclear.
Ourresultsshowednodiscernablediﬀerencesincaspase-
1 activation between fASC and vASC. However, the levels
of excreted IL-1β in the medium was signiﬁcantly higher
in vASC transfectants than in fASC transfectants, and
immunostaining revealed remarkable diﬀerences in aggre-
gate formation and ASC distribution.
The PGR domain contains three glycine and four proline
residues. Glycine is known to confer ﬂexibility to protein
structures [19], making them candidates to act as movable
hinges. Proline motifs are also found in molecular hinges,Mediators of Inﬂammation 5
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Figure 6: Hypothesized structure of fASC and vASC showing the
PGR domain hinge.
and α-helice conformational changes can be generated by a
proline-hinge in transmembrane proteins [20, 21]. Thus, the
PGR domain may impart a bending property to ASC and
can be considered to be a hinge between the PYD and CARD
domainsthatisfoldedintheinactiveformofASC(Figure6).
Our results with the “hingeless” vASC support this notion in
that unfoldable ASC may have been constitutively activated
and formed branched ﬁbrous aggregates in cells expressing
the product.
In terms of IL-1β released, the preventative eﬀects
of glycine on proIL-1β,b u tn o tI L - 1 β, released from
macrophages [22] and regulation by Ca2+ on IL-1β release
from lysosomes via exocytotic fusion [23]h a v eb e e n
reported. The involvement of fASC or vASC in the release
of IL-1β is unclear, however. Together with a strong electric
dipole moment of the PYD domain of ASC [24], our present
results suggest that the PGR domain may aﬀect the 3-
dimensional structure of ASC and thus play an important
role in the activation of ASC.
5. Conclusion
vASC lacking the PGR domain excreted higher levels of IL-
1β and formed a more ﬁbrous aggregation than fASC. We
hypothesize that this domain plays the structural role of a
hinge between PYD and CARD domains. fASC may be in an
inactive folded state in the absence of ligands, whereas vASC
may be in a permanently active state.
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